Press release
Gradient Ascent Capital Launches the CRISPR Index, the World’s First Equity Index Tracking the CRISPR Gene Editing Technology
June 20, 2017 - Gradient Ascent Capital, an emerging technology equity index provider, announced the launch of the Gradient Ascent Capital CRISPR Index, which is the first equity index in the world created to track the performance of companies developing and using the revolutionary CRISPR/Cas technology for gene editing and genetic engineering.The index is a capitalization-weighted index designed to measure the performance of companies that stand to significantly benefit from the advancement of the CRISPR/Cas family of genome editing techniques. The index has been backtested to January 4, 2016 with a base value of 1,000.
ABOUT GRADIENT ASCENT CAPITAL
Gradient Ascent Capital creates and manages equity indexes that track companies driving the most promising emerging technologies of tomorrow. Using a unique blend of industry experience and insight, along with proprietary data mining and artificial intelligence techniques, Gradient Ascent Capital provides investors novel ways to track and invest in the future. Learn more at http://www.gradientascentcapital.com
Gradient Ascent Capital
1684 Decoto Rd, #196
Union City, CA 94587
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gradient Ascent Capital Launches the CRISPR Index, the World’s First Equity Index Tracking the CRISPR Gene Editing Technology here
News-ID: 586878 • Views: …
More Releases from Gradient Ascent Capital
Gradient Ascent Capital Launches the Machine Learning Index, the World’s First …
June 20, 2017 - Gradient Ascent Capital, an emerging technology equity index provider, announced the launch of the Gradient Ascent Capital Machine Learning Index, which is the first equity index in the world created to track the performance of companies developing and using computational machine learning technologies to improve the capability of computers across a vast array of applications, including computer vision, natural language processing, and speech recognition.
The index…
More Releases for CRISPR
Amerigo Scientific Unveils CRISPR/Cas Enzymes to Expand the CRISPR Toolbox
Amerigo Scientific, as a distributor focused on providing critical products and services to biomedical and life science communities, announced the release of a groundbreaking selection of CRISPR/Cas enzymes to its extensive life science portfolio, aimed at further expanding the vast potential of the CRISPR toolbox. This addition brings cutting-edge genetic editing tools to scientists and researchers in a variety of fields.
CRISPR/Cas (Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-associated) technology revolutionized the…
CRISPR Technology Market - Gene Editing Redefined: Pioneering CRISPR Technology …
Newark, New Castle, USA: The "CRISPR Technology Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
CRISPR Technology Market: https://www.growthplusreports.com/report/crispr-technology-market/7632
This latest report researches the industry structure, sales,…
CRISPR And CRISPR-Associated (Cas) Genes Market Analysis & Trends - Industry For …
LOS ANGELES, United States: The research study presented in this report offers a complete and intelligent analysis of the competition, segmentation, dynamics, and geographical advancement of the global CRISPR And CRISPR-Associated (Cas) Genes market. It takes into account the CAGR, value, volume, revenue, production, consumption, sales, manufacturing cost, prices, and other key factors related to the global CRISPR And CRISPR-Associated (Cas) Genes market. The authors of the report have segmented…
CRISPR & Cas Genes Market Dynamic Growth Factors 2028 | CRISPR Therapeutics, Ast …
"CRISPR & Cas Genes Market" Report offers an in-depth analysis of the market size, share, SWOT Analysis, future progress expansion, industry growth, key development strategies and market trend dynamics which includes drivers, restraints, opportunities prevailing in the industry by product type, application, key manufacturers and key regions and countries.
It also offers advanced statistics as well as some business-driven information associated with the precise industry. It delivers an analytical investigation of the…
CRISPR and CRISPR-Associated (Cas) Genes Market 2022 | Detailed Report
According to Market Study Report, CRISPR and CRISPR-Associated (Cas) Genes Market provides a comprehensive analysis of the CRISPR and CRISPR-Associated (Cas) Genes Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team.
Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4240401
The report provides a comprehensive analysis of company profiles listed below:
-…
CRISPR and CRISPR-Associated (Cas) Genes Market 2021 | Detailed Report
The CRISPR and CRISPR-Associated (Cas) Genes research report undoubtedly meets the strategic and specific needs of the businesses and companies. The report acts as a perfect window that provides an explanation of market classification, market definition, applications, market trends, and engagement. The competitive landscape is studied here in terms of product range, strategies, and prospects of the market’s key players. Furthermore, the report offers insightful market data and information about…
